Elsewhere on Ulster
This project is funded by:
Despite significant advances in the treatment and management of cardiovascular disease (CVD), it remains the leading cause of morbidity and mortality worldwide. As a high proportion of cases are attributable to modifiable risk factors, prevention strategies are urgently needed to reduce the burden of this disease.
Strong evidence supports nutrition and lifestyle interventions as effective tools for improving cardiometabolic risk factors, however, scalability, long-term adherence, and sustained engagement remain key limitations of conventional approaches.
Digital tools have emerged as an effective solution to deliver health-related interventions to overcome these challenges. Moreover, response to interventions is affected by both individual variability in biological factors such as age, sex, genetics and the gut microbiome, and in dietary-related preferences and behaviours.
Thus, personalised nutrition has emerged as a promising strategy with a recent study demonstrating the effectiveness of an app-based programme, integrating multimodal data, on cardiometabolic markers compared with standard dietary advice.
As regards nutrition, we previously demonstrated cardiovascular benefits of riboflavin in individuals genetically at increased risk of hypertension owing to a common genetic variant, the MTHFR C677T polymorphism. However, the benefits of increasing intakes of foods rich in riboflavin on blood pressure and other cardiovascular markers in genetically at-risk individuals has not been investigated.
The overall aim of this project is to explore interactions between biological, lifestyle and environmental factors to inform the delivery of a novel, state of the art AI-driven, digitally delivered personalised nutrition and lifestyle programme to prevent cardiovascular disease in at-risk adults.
This will involve in-depth investigations using an existing resource for ageing research (the TUDA study) and delivering a randomised controlled trial in at-risk individuals incorporating AI and biological, behavioural and environmental personalisation.
The project outcomes will lead to improved nutrition and metabolic outcomes in at risk individuals and translation of the intervention into routine healthcare to prevent cardiometabolic disorders.
Please note: Research Proposal - 5 pages in total
The proposal must include:
Please also note that the use of AI in generating the research proposal is prohibited.
Important Information: Applications for more than one PhD studentship are welcome, however if you apply for more than one PhD project within Biomedical Sciences/Pharmacy and Pharmaceutical Sciences, your first application on the system will be deemed your first-choice preference and further applications will be ordered based on the sequential time of submission.
If you are successfully shortlisted, you will be interviewed only on your first-choice application and ranked accordingly. Those ranked highest will be offered a PhD studentship.
In the situation where you are ranked highly and your first-choice project is already allocated to someone who was ranked higher than you, you may be offered your 2nd or 3rd choice project depending on the availability of this project.
Applicants should hold, or expect to obtain, a First or Upper Second Class Honours Degree in a subject relevant to the proposed area of study.
We may also consider applications from those who hold equivalent qualifications, for example, a Lower Second Class Honours Degree plus a Master’s Degree with Distinction.
In exceptional circumstances, the University may consider a portfolio of evidence from applicants who have appropriate professional experience which is equivalent to the learning outcomes of an Honours degree in lieu of academic qualifications.
If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.
The University is an equal opportunities employer and welcomes applicants from all sections of the community, particularly from those with disabilities.
Appointment will be made on merit.
This project is funded by:
PhD Scholarships are available for this project and will cover:
To be eligible for these scholarships applicants must: be a UK or Irish national; or have pre-settled or settled status; or have indefinite leave to remain or enter.
Applicants should also meet the residency criteria which requires that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme i.e. September 2027.
Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year, or part-time equivalent, funded from any source, including self-financing students, are NOT eligible to apply for an award.
Students in full-time employment are not eligible for an award.
Due consideration should be given to financing your studies.
Part-time PhD scholarships may be available at a 0.5 pro rata rate of the full-time scholarship, which would require a six-year registration period.
The University will award a successful candidate one of the following scholarships for the project, depending on the funding available at the time an admissions offer is made:
Please note that the Terms and Conditions for scholarships are subject to change for 2027/28.
Adams SH, Anthony JC, Carvajal R, et al. Perspective: Guiding Principles for the Implementation of Personalized Nutrition Approaches That Benefit Health and Function. Adv Nutr. 2020;11(1):25-34. doi:10.1093/ADVANCES/NMZ086
Bermingham KM, Linenberg I, Polidori L, et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nat Med. 2024;30(7):1888-1897. doi:10.1038/s41591-024-02951-6
Livingstone KM, Ramos-Lopez O, Pérusse L, Kato H, Ordovas JM, Martínez JA. Precision nutrition: A review of current approaches and future endeavors. Trends Food Sci Technol. 2022;128:253-264. doi:10.1016/J.TIFS.2022.08.017
McNulty H, Strain JJ, Hughes CF, Ward M. Riboflavin, MTHFR genotype and blood pressure: A personalized approach to prevention and treatment of hypertension. Mol Aspects Med. 2017;53:2-9. doi:10.1016/j.mam.2016.10.002
McNulty H, Strain JJ, Hughes CF, Pentieva K, Ward M. Evidence of a role for one-carbon metabolism in blood pressure: Can B vitamin intervention address the genetic risk of hypertension owing to a common folate polymorphism? Curr Dev Nutr. 2019;4(1):1-8. doi:10.1093/cdn/nzz102
Ward M, Hughes CF, Strain J, et al. Impact of the common MTHFR 677C→T polymorphism on blood pressure in adulthood and role of riboflavin in modifying the genetic risk of hypertension: evidence from the 2 JINGO project 3 4. BMC Med. 2020;18(318):1-11. doi:10.1186/s12916-020-01780-x
Submission deadline
Friday 8 January 2027
04:00PM
Interview Date
between 8 -16 February 2027
Preferred student start date
13 September 2027
Telephone
Contact by phone
Email
Contact by email